U.S. Food Stock News

Wondering whether HNI at around US$37.30 is priced for opportunity or already reflects its potential? This article focuses squarely on what the current share price might be implying. HNI's share price sits at US$37.30 after returns of 2.9% over the past week and 9.7% over the past month. Year to date the stock shows a 12.4% decline and a 6.5% decline over the last year, set against a 60.8% gain over three years and 6.3% over five years. Recent coverage around HNI has focused on its position...

MSCI (MSCI) opened 2026 with Q1 revenue of US$850.8 million and basic EPS of US$5.54, with trailing 12 month EPS at US$17.50 and net income of about US$1.3b framing the latest print. Over the last five reported quarters, revenue has moved from US$745.8 million in Q1 2025 to US$850.8 million in Q1 2026, while quarterly basic EPS has ranged from US$3.72 to US$5.54 over the same period. This gives a clearer picture of top line scale and earnings power. With a trailing net profit margin of 40.7%...

FTAI Aviation (NasdaqGS:FTAI) has launched FTAI Power, a new platform focused on repurposing retired jet engines for AI data centers. The company also announced a second structured aircraft acquisition program, expanding its approach to sourcing and financing aircraft assets. These moves signal a wider set of opportunities for FTAI Aviation beyond traditional aviation leasing and engine services. FTAI Aviation operates in aircraft leasing and engine management, and now it is stepping...

Wondering if FirstCash Holdings at around US$208 a share still offers value, or if most of the upside is already priced in. The stock has returned 2.6% over the last week, 8.3% over the past month, 32.7% year to date and 73.0% over the last year, with 3 year and 5 year returns of 125.1% and 207.7% respectively. Recent coverage has focused on FirstCash Holdings' role in consumer finance and how its pawn and retail operations fit into broader credit conditions. This helps frame expectations...

Synchrony Financial (SYF) opened 2026 with Q1 revenue of US$2,363 million and basic EPS of US$2.32, setting the tone for its latest earnings update. The company has seen revenue move from US$2,227 million in Q1 2025 to US$2,363 million in Q1 2026, while trailing twelve month EPS sits at US$10.12 on net income of US$3,517 million. This gives investors a clear read on how profitability is tracking into the new year. With margins currently framed by this earnings run rate, the quarter gives...

Wondering if Axcelis Technologies at around US$133 per share still offers value, or if most of the upside may already be reflected in the price. The stock has posted returns of 17.8% over 7 days, 57.8% over 30 days, 54.7% year to date and 195.3% over 1 year. This naturally raises questions about potential growth and shifts in perceived risk. These sharp moves sit against a backdrop of ongoing investor interest in semiconductor equipment providers and how they fit into longer term chip...

Peoples Bancorp of North Carolina (PEBK) opened 2026 with Q1 revenue of US$21.0 million and basic EPS of US$0.83, supported by trailing twelve month revenue of US$89.9 million and EPS of about US$3.75 as profitability strengthened over the past year. The bank has seen trailing EPS move from about US$3.08 to roughly US$3.75 over the last six reported quarters, while net income over the same trailing period reached US$19.9 million. This sets up the latest result against an earnings profile that...

AMC Robotics (AMCI) has just wrapped up FY 2025 with Q4 revenue of US$1.3 million and a basic EPS loss of US$0.52, while trailing twelve month figures show revenue of US$6.0 million and a basic EPS loss of US$1.36 alongside a reported 41.4% revenue decline over the year. Over the past few reported periods, quarterly revenue has ranged from US$1.3 million to US$3.2 million and basic EPS has swung between a profit of US$0.15 and a loss of US$0.52, underscoring how volatile the earnings line has...

IDEAYA Biosciences (NasdaqGS:IDYA) has entered a clinical collaboration with AstraZeneca to study IDE849, a DLL3 TOP1 antibody drug conjugate. The program will evaluate IDE849 in combination with Imfinzi in extensive stage small cell lung cancer and other DLL3 upregulated tumors. For readers tracking IDEAYA mainly through its uveal melanoma drug darovasertib, this collaboration with AstraZeneca broadens the story. The company, trading at $31.83, has delivered a 70.9% return over the past...

Wintrust Financial (WTFC) opened 2026 with Q1 revenue of US$682.4 million and basic EPS of US$3.26, while trailing twelve month revenue stood at US$2.7 billion and EPS at US$12.10. This gives investors a clear snapshot of both the latest quarter and the broader earnings run rate. Over the past year, revenue has moved from US$2.3 billion to US$2.7 billion and trailing EPS has shifted from US$10.47 to US$12.10, setting the backdrop for how the market may read this earnings print. With a...

If you are wondering whether Calix at around US$49.58 still offers value or is starting to look stretched, the key is to look closely at what you are paying for each dollar of its future potential. The share price performance is mixed, with a 1.6% gain over the last 7 days, a 1.5% decline over 30 days, a 7.5% decline year to date, and a 31.8% return over the past year. These shifts can change how the market views both risk and opportunity. Investors have been reacting to ongoing industry...

Progress Software (PRGS) shares are in focus after the company announced a relocation and expansion of its Bengaluru office, highlighting India’s growing role in its AI work and customer facing operations. See our latest analysis for Progress Software. The Bengaluru expansion comes at a time when Progress Software’s share price return has weakened, with a 29.6% decline over 90 days and a 46.9% drop in 1 year total shareholder return. This is despite a 6.7% 7 day share price rebound that hints...

Mueller Industries (MLI) opened Q1 2026 with revenue of US$1.2b and basic EPS of US$2.19, supported by net income of US$239.0m. This sets a clear marker for how the year is starting to shape up. Over the past year, the company has seen trailing twelve month revenue move from US$3.8b to US$4.4b, with basic EPS over that period rising from US$5.43 to US$7.76. This gives investors a fuller picture of the earnings engine behind the latest quarterly print. With a trailing net margin sitting...

Q1 2026 earnings snapshot Danaher (DHR) opened 2026 with Q1 revenue of US$5.9b and basic EPS of US$1.45, setting the tone for how investors will judge the rest of the year against a share price around US$194.54. Over the past six reported quarters, revenue has ranged from US$5.7b to US$6.8b while quarterly basic EPS has moved between roughly US$0.77 and US$1.67, giving you a clear view of how top line scale and per share earnings have tracked together into the latest print. With trailing 12...

If you are wondering whether Semtech's share price still reflects good value after a strong run, it helps to step back and look at what the current valuation is really pricing in. The stock last closed at US$103.48, with returns of 14.8% over 7 days, 40.6% over 30 days, 37.5% year to date and 319.1% over the past year. Any view on value now needs to factor in that kind of move. Recent news coverage has focused on Semtech's position within the broader semiconductor space and how investors are...

Valmont Industries (VMI) opened 2026 with Q1 revenue of US$1,029.2 million and basic EPS of US$5.55, setting the tone for how the year is starting to shape up after a mixed run through 2025. Over recent quarters the company has seen revenue move from US$969.3 million and EPS of US$4.35 in Q1 2025 through periods such as Q2 2025, when it generated US$1,050.5 million of revenue but reported a loss with basic EPS of US$1.53, before closing 2025 with Q4 revenue of US$1,038.3 million and EPS of...

Equifax Q1 2026 earnings in focus Equifax (EFX) opened 2026 with Q1 revenue of US$1.6 billion and basic EPS of US$1.43, backed by trailing twelve month EPS of US$5.72 and net income of US$698.7 million as investors weigh what these results say about earnings momentum. The company has seen revenue move from US$1,442 million and EPS of US$1.07 in Q1 2025 to US$1,648.9 million and EPS of US$1.43 in Q1 2026, while trailing twelve month revenue and EPS have shifted from US$5.7 billion and US$4.94...

What Lennox International’s recent performance means for investors Lennox International (LII) has drawn fresh attention after a mixed stretch in its share performance, with gains over the past month alongside negative returns over the past 3 months and year. At a last close of US$492.69, the company carries a market value of about US$17.2b. This is supported by annual revenue of US$5.2b and net income of US$805.8m across its residential and commercial HVAC and refrigeration operations. See...

Cleveland-Cliffs (CLF) opened 2026 with Q1 revenue of US$4.9b and a basic EPS loss of US$0.42, with trailing twelve month revenue at US$18.9b against a net loss from continuing operations of US$1.2b. Over the past year of reported quarters, revenue has ranged between US$4.3b and US$4.9b while quarterly basic EPS has stayed in loss territory from US$0.50 to US$1.00 per share, keeping margins under clear pressure despite a relatively stable top line. See our full analysis for...

JBT Marel (NYSE:JBTM) is bringing its Wenger and Extru-Tech brands together for the first time at Petfood Forum 2026. The combined presence will highlight solutions for minimally processed, nutrient-dense pet food manufacturing. The move showcases new equipment offerings and closer alignment across JBT Marel’s pet food processing portfolio. For investors tracking NYSE:JBTM, this joint showcase comes with the shares at $132.63 and a 1 year return of 40.4%. The stock has also recorded a 30.8%...

United Community Banks (UCBI) opened 2026 with Q1 total revenue of US$265.7 million and basic EPS of US$0.69, while trailing twelve month revenue stood at US$1.0 billion and EPS at US$2.74. This gives investors a clear read on both the latest quarter and the broader run rate. Over the past few quarters, revenue has moved from US$232.3 million in Q1 2025 to US$265.7 million in Q1 2026 and EPS has shifted from US$0.58 to US$0.69, with trailing net income rising from US$244.6 million in Q4 2024...

Columbia Financial (CLBK) opened 2026 with Q1 revenue of US$66.2 million and basic EPS of US$0.13, anchored by net income of US$13.1 million. This puts fresh numbers behind the company’s recent return to profitability. The business has seen revenue move from US$55.9 million and EPS of US$0.09 in Q1 2025 to US$66.2 million and EPS of US$0.13 in Q1 2026, with trailing twelve month EPS at US$0.55 as the earnings base rebuilds. With a Q1 net interest margin of 2.42% and a cost to income ratio of...

CoastalSouth Bancshares (COSO) opened 2026 with Q1 total revenue of US$21.3 million and basic EPS of US$0.53, supported by net income of US$6.3 million. Over recent quarters, total revenue has moved from US$18.0 million in Q1 2025 to US$21.3 million in Q1 2026, while quarterly EPS has ranged from US$0.49 to US$0.60 across that period. This provides a clearer view of how the income statement is scaling. With a trailing net profit margin of 31.6% holding steady and a net interest margin of...

CNB Financial (CCNE) has just reported Q1 2026 results, with revenue of about US$82.3 million and basic EPS of US$0.88 setting the tone for the quarter, backed by trailing twelve month revenue of US$300.3 million and EPS of US$2.87. Over recent periods the company has seen revenue move from US$56.4 million in Q4 2024 to US$55.4 million in Q1 2025, then to US$82.3 million in Q1 2026. Quarterly EPS shifted from US$0.66 to US$0.50 and now US$0.88, giving investors a clearer view of how the...